Biopharma exports to US 'to top €24bn'
Ireland's pharma exports to the US will top €24bn in a record year for the sector, but the volatility of the Trump administration poses a risk to that growth, a Dublin business conference has been told.
"Exports at record levels from the biopharma sector represent a remarkable achievement," said Ibec chief executive Danny McCoy.
"Given the wider political and economic uncertainties from factors like Brexit, this is even more impressive."
Recruitment firm Ardlinn, which co-hosted the event with Ibec, said the number of people working in the pharma sector here has doubled in the past two decades to well above 40,000.
She said pharma exports to the US appeared on course for further growth in 2020. "That said, we cannot be complacent and must take steps to mitigate risks for this crucial market," said Ardlinn director Áine Brolly.
The €24bn forecast for 2019 is based on CSO figures.
Please log in or register with belfasttelegraph.co.uk for free access to this article.